Human Molecular Genetics, Third Edition
Description:
Professors Tom Strachan & Andrew Read awarded the Education Award 2007 of the ESHG for their outstanding contribution to the dispersal of knowledge of modern human molecular genetics among students and professionals.
Following the completion of the Human Genome Project the content and organization of the third edition of Human Molecular Genetics has been thoroughly revised.
* Part One (Chapters 1-7) covers basic material on DNA structure and function, chromosomes, cells and development, pedigree analysis and the basic techniques used in the laboratory.
* Part Two (Chapters 8-12) discusses the various genome sequencing projects and the insights they provide into the organisation, expression, variation and evolution of our genome.
* Part Three (Chapters 13-18) focuses on mapping, identifying and diagnosing the genetic causes of mendelian and complex diseases and cancer.
* Part Four (Chapters 19-21) looks at the wider horizons of functional genomics, proteomics, bioinformatics, animal models and therapy.
There are new chapters on cells and development and on functional genomics. The sections on complex diseases have been completely rewritten and reorganized, as has the chapter on Genome Projects. Other changes include a new section on molecular phylogenetics (Chapter 12) and the introduction of 'Ethics Boxes' to discuss some of the implications of the new knowledge. Virtually every page has been revised and updated to take account of the stunning developments of the past four years since the publication of the last edition of Human Molecular Genetics.
Features:
* Integration of Human Genome Project data throughout the book
* Two new chapters 'Cells and Development' (Chapter 3) and 'Beyond the Genome Project: Functional Genomics, Proteomics and Bioinformatics' (Chapter 19)
* Completely rewritten and reorganised coverage of complex disease genetics
* Increased emphasis on gene function and on applications of genetic knowledge, including ethical issues
* More prominence given to novel approaches to treating disease, such as cell-based therapies, pharmacogenomics, and personalised medicine
* Special topic boxes that include detailed coverage of ethical, legal and social issues, including eugenics, genetic testing and discrimination, germ-line gene therapy and genetic enhancement, and human cloning
* Contains two indices: a general index and one that contains names of diseases and disorders
Supplements:
Art of HMG3 (CD-ROM) 0-8153-4183-0: £34.00
Best prices to buy, sell, or rent ISBN 9780815341826
Related Books
- 1
- 2
- 3
- 4
- Art Human Molecular Genetics 3Strachan, Tom; Strachan, T.Edition:3rd EdISBN-13:9780815341833
- Human Molecular GeneticsStrachan, Tom; Read, Andrew P.Edition:1ISBN-13:9780471133735
- Human Molecular Genetics 2Strachan, Tom; Read, Andrew P.Edition:2ndISBN-13:9780471330615
- Human Molecular Genetics, Fourth EditionStrachan, Tom; Read, AndrewEdition:4ISBN-13:9780815341499
- Art Human Molecular Genetics 3Strachan, Tom; Strachan, T.Edition:3rd EdISBN-13:9780815341833
- Human Molecular GeneticsStrachan, Tom; Read, Andrew P.Edition:1ISBN-13:9780471133735
Frequently Asked Questions about Human Molecular Genetics, Third Edition
The price for the book starts from $7.55 on Amazon and is available from 22 sellers at the moment.
At BookScouter, the prices for the book start at $3.90. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the Human Molecular Genetics, Third Edition book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Human Molecular Genetics, Third Edition book, the best buyback offer comes from and is $ for the book in good condition.
The Human Molecular Genetics, Third Edition book is in very low demand now as the rank for the book is 5,443,615 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.